Dual Targeting EGFR and STAT3 With Erlotinib and Alantolactone Co-Loaded PLGA Nanoparticles for Pancreatic Cancer Treatment

by Shihui Bao, Shihui Bao, Hailun Zheng, Hailun Zheng, Jinyao Ye, Jinyao Ye, Jinyao Ye, Jinyao Ye, Huirong Huang, Huirong Huang, Huirong Huang, Bin Zhou, Bin Zhou, Qing Yao, Guangyong Lin, Guangyong Lin, Hailin Zhang, Hailin Zhang, Longfa Kou, Longfa Kou, Ruijie Chen, Ruijie Chen
Published 2021-03-01